Pure Global

Clinical Trial - Trial ChiCTR2200057850

Access comprehensive clinical trial information for ChiCTR2200057850 through Pure Global AI's free database. This Phase 2 trial is sponsored by HENAN PROVINCIAL PEOPLE'S HOSPITAL and is currently Not yet recruiting. The study focuses on gastric cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200057850
Phase 2
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry โ€ข ChiCTR2200057850
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Efficacy and safety of xindilimab combined with oxaliplatin / capecitabine (XELOX) in neoadjuvant therapy of locally advanced gastric cancer: a prospective, single center, phase II study

Study Focus

gastric cancer

Sponsor & Location

HENAN PROVINCIAL PEOPLE'S HOSPITAL

The cost of continuous blood glucose test and ambulatory electrocardiogram in this study shall be paid by themselves according to the hospitalization charging process; However, the cost of subsequent

China

Timeline & Enrollment

Phase 2

N/A

Mar 08, 2023

ICD-10 Classifications

Gastric ulcer
Malignant neoplasm of stomach
Malignant neoplasm: Body of stomach
Carcinoma in situ: Stomach
Malignant neoplasm: Stomach, unspecified

Data Source

Chinese Clinical Trial Registry

ChiCTR2200057850

Non-Device Trial